Report overview
The global Biologics Contract Manufacturing Service market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Monoclonal Antibodies segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Biologics Contract Manufacturing Service include Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Biologics Contract Manufacturing Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Biologics Contract Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Contract Manufacturing Service. This report contains market size and forecasts of Biologics Contract Manufacturing Service in global, including the following market information:
Global Biologics Contract Manufacturing Service market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Biologics Contract Manufacturing Service companies in 2024 (%)
Total Market by Segment:
Global Biologics Contract Manufacturing Service market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Biologics Contract Manufacturing Service market segment percentages, by Type, 2024 (%)
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Molecular Therapy
Others
Global Biologics Contract Manufacturing Service market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Biologics Contract Manufacturing Service market segment percentages, by Application, 2024 (%)
Large Pharmaceutical Companies
Small And Medium Pharmaceutical Companies
Global Biologics Contract Manufacturing Service market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Biologics Contract Manufacturing Service market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics Contract Manufacturing Service revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Biologics Contract Manufacturing Service revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza Group
Samsung Biologics
Thermo Fisher Scientific
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics Contract Manufacturing Service, market overview.
Chapter 2: Global Biologics Contract Manufacturing Service market size in revenue.
Chapter 3: Detailed analysis of Biologics Contract Manufacturing Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics Contract Manufacturing Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
